Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program

被引:0
|
作者
Jean-Marc Krähenbühl
Anne Decollogny
Olivier Bugnon
机构
[1] University of Geneva,Ambulatory Care and Community Medicine Department, Community Pharmacy Unit, Pharmaceutical Science Section
[2] University of Lausanne,Institute of Health Economics and Management
来源
Pharmacy World & Science | 2008年 / 30卷
关键词
Community pharmacy; Drug costs; Drug-related problems; Medication Review; Positive predictive value; Switzerland;
D O I
暂无
中图分类号
学科分类号
摘要
Objectives To measure the positive predictive value (PPV) of the cost of drug therapy (threshold = 2000 Swiss francs [CHF], US$1440, €1360) as a screening criterion for identifying patients who may benefit from medication review (MR). To describe identified drug-related problems (DRPs) and expense problems (EPs), and to estimate potential savings if all recommendations were accepted. Setting Five voluntary Swiss community pharmacies. Methods Of 12,680 patients, 592 (4.7%) had drug therapy costs exceeding 2000 CHF over a six-month period from July 1 to December 31, 2002. This threshold limit was set to identify high-risk patients for DRPs and EPs. Three pharmacists consecutively conducted a medication review based on the pharmaceutical charts of 125 sampled patients who met the inclusion criterion. Main outcome measure The PPV of a threshold of 2000 CHF for identifying patients who might benefit from a MR: true positives were patients with at least one DRP, while false positives were patients with no DRP. Results The selection based on this criterion had a PPV of 86% for detecting patients with at least one DRP and 95% if EPs were also considered. There was a mean of 2.64 (SD = 2.20) DRPs per patient and a mean of 2.14 (SD = 1.39) EPs per patient. Of these patients, 90% were over 65 years old or were treated with at least five chronic medications, two common criteria for identifying patients at risk of DRPs. The main types of DRPs were drug–drug interactions, compliance problems and duplicate drugs. Mean daily drug cost per patient was CHF 14.87 (US$10.70, €10.10). A potential savings of CHF 1.67 (US$1.20, €1.14) per day (11%) was estimated if all recommendations to solve DRPs and EPs suggested herein were implemented. Conclusion Further studies should investigate whether the potential benefit of medication reviews in preventing DRPs and containing costs in this patient group can be confirmed in a real practice environment
引用
收藏
页码:816 / 822
页数:6
相关论文
共 50 条
  • [31] The Patient Experience in a Community Pharmacy-Based Mental Illness and Addictions Program
    Murphy, Andrea
    Jacobs, Lisa
    Gardner, David
    [J]. INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 2019, 18
  • [32] DEVELOPING AND IMPLEMENTING A COMMUNITY PHARMACY-BASED PROGRAM FOR IMPROVING QUALITY MEASURES
    Vermeulen, David
    Frail, Caitlin
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (05): : E4 - E4
  • [33] Self-Medication Practices from the Perspective of Tunisian Cardiovascular Patients - A Community Pharmacy-Based Survey
    Suciu, Maria
    Vlaia, Lavinia
    Boujneh, Eya
    Suciu, Liana
    Buda, Valentina Oana
    Vlaia, Vicentiu
    Cristescu, Carmen
    [J]. AMERICAN HEART JOURNAL, 2022, 254 : 256 - 257
  • [34] A REGIONAL PHARMACY-BASED ADVERSE DRUG-REACTIONS SURVEILLANCE PROGRAM
    DEKONING, GHP
    LEUFKENS, HGM
    DEKKER, AMS
    MUTSAERTS, KJGM
    [J]. PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (02) : 143 - 143
  • [35] Costs and Effects Associated with a Community Pharmacy-Based Smoking-Cessation Programme
    Grainne E. Crealey
    James C. McElnay
    Terry A. Maguire
    Ciaran O’Neill
    [J]. PharmacoEconomics, 1998, 14 : 323 - 333
  • [36] Costs and effects associated with a community pharmacy-based smoking-cessation programme
    Crealey, GE
    McElnay, JC
    Maguire, TA
    O'Neill, C
    [J]. PHARMACOECONOMICS, 1998, 14 (03) : 323 - 333
  • [37] Influence of a pharmacy-based transplant patient medication assistance program on length of stay (LOS), re-admissions, and costs.
    Jarrett, Anne
    Svejkovsky, Lori
    Doares, William
    Ashcraft, Elizabeth
    Farney, Alan
    Hartman, Erica
    Rogers, Jeff
    Adams, Patricia
    Stratta, Robert
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 396 - 396
  • [38] Development of a community pharmacy-based intervention for patients with uncontrolled asthma
    Turcotte, Claudie
    Fenelon-Dimanche, Rebecca
    Lemiere, Catherine
    Beauchesne, Marie-France
    Abou-Atme, Bachir
    Chabot, Isabelle
    Blais, Lucie
    [J]. EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2022, 7
  • [39] Pilot Project to Implement a Community Pharmacy Medication Review Program
    Dupuis, Sebastien
    Turgeon, Nathalie
    Beauchesne, Marie-France
    [J]. CANADIAN PHARMACISTS JOURNAL, 2011, 144 (03) : 116 - 118
  • [40] Community Pharmacy-Based Inducement Programs Associated With Better Medication Adherence: A Cohort Study
    Simpson, Scot H.
    Lin, Mu
    Eurich, Dean T.
    [J]. ANNALS OF PHARMACOTHERAPY, 2017, 51 (08) : 630 - 639